See other companies on Welcome to the Jungle
Antidote
Patient recruitment marketplace for clinical trials
- 21-100 employees
- Healthcare
- B2C
- B2B
- Marketplace
- Recruitment
- Market research
- Midtown East, New York, NY
Jump to section
Company mission
Antidote's mission is to transform the way that sponsors and patients connect in order to accelerate medical research.
Our take
According to Antidote, most clinical trials are delayed or closed due to lack of participants. This is a big problem and slows how quickly new treatments can come to market.
Antidote uses precision recruitment to match the right patients with the right trials, striking the right balance between technology and human touch to deliver high-quality patient engagement. This is achieved through the integration of data-driven technologies, digital expertise, deep domain experience, an extensive diverse partner network, and personalized patient and site services.
In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue. Funding is allowing the company to build on its commercial success and accelerate growth. The company is enhancing its clinical trial search engine, launching new products and services, and expanding its footprint internationally. The current CEO has over 30 years of experience in pharmaceuticals, so is well placed to continue this rapid growth over the coming years.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Health benefits and retirement package
- Flexible schedules and remote working
- Generous vacation and paid holidays
- Your birthday off
- Monthly wellbeing subsidy
- Remote working stipend and home setup allowance
- Learning and development opportunities
- Virtual company events and happy hours
Company values
- We care
- We collaborate
- We trust
- We deliver
Funding (last 2 of 5 rounds)
Jun 2021
$23m
LATE VC
Sep 2017
$11m
EARLY VC
Total funding: $51.9m
This company has top investors
Leadership
Laurent Schockmel
(CEO)Previous Managing Partner at Purple Vault LLC and Senior Vice President of Business Development at Truveris, before becoming CEO of Antidote in 2018.
People progressing
Joined as an Intern and promoted to Clinical Associate after 8 months. Current Product Manager for Antidote.